Details of the Drug
General Information of Drug (ID: DMKFSNG)
| Drug Name |
Ad VEGF-C
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | Lymfactin; VEGF-based gene therapy, Ark Therapeutics; VEGF C-based adenoviral vector gene therapy (lymphoedema), Oy Lx Therapies | ||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
